The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next-generation sequencing (NGS) market is ...
Current genetic screening guidelines fail to identify most people with an inherited condition known as familial ...
Scientists at Brigham and Women's Hospital and Harvard Medical School have developed a targeted genetic test to improve ...
Diabetes is not just about elevated blood glucose levels. It is a chronic condition capable of inflicting slow, irreversible ...
Colorado legislators on Tuesday heard from an advisory committee, which proposed making several adjustments to the state’s ...
Digital health’s 2025 shape is pretty clear: money is flowing again, AI is getting absorbed into real workflows, and policy ...
Members of Colorado’s Joint Budget Committee on Tuesday heard from the state’s Medicaid Provider Rate Review Advisory ...
Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM ESTCompany ParticipantsSteve Chapman - CEO & ...
3don MSN
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat
On October 29, 2025, Guggenheim lifted GeneDx (NASDAQ:WGS) to a $170 price target (Buy) after the company’s blow-out Q3 ...
Oncologists at Suraksha Diagnostic discuss early detection, screening, prevention and rising cancer incidence across age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback